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Background: A national multimedia campaign was launched in January 2010, to increase the proportion of young
people tested for chlamydia. This study aimed to evaluate the impact of the campaign on the coverage and
positivity within the National Chlamydia Screening Programme (NSCP) in England.
Method: An interrupted time series of anonymised NCSP testing reports for England for a 27 month period
(1st April 2008 to 30th June 2010) was analysed. Reports were assigned to a pre-campaign, campaign and post
campaign phase according to the test date. Exclusion criteria included tests for clinical reasons, contacts of known
cases, and tests returned from prisons or military services.
Negative binomial and logistic regression modelling was used to provide an estimate for the change in coverage
and positivity, during, and after the campaign and estimates were adjusted for secular and cyclical trends.
Results: Adjusting for cyclical and secular trends, there was no change in the overall testing coverage either during
(RR: 0.91; 95% CI: 0.72-1.14) or after (RR: 0.88; 95%CI: 0.69-1.11) the campaign. The coverage varied amongst different
socio-demographic groups, testing of men increased during the campaign phase while testing of people of black
and other ethnic groups fell in this phase. The positivity rate was increased during the campaign (OR: 1.18; 95% CI
1.13-1.23) and further increased in the post-campaign phase (OR: 1.40; 95% CI 1.30-1.51). The proportion of
chlamydia infections detected increased for all socio-demographic and self-reported sexual behaviour groups both
during and after the campaign.
Conclusion: The uptake of chlamydia testing rose during the campaign; however, this apparent increase was not
maintained once overall trends in testing were taken into account. Nonetheless, once secular and cyclical trends
were controlled for, the campaign was associated with an increased positivity linked to increased testing of high
risk individuals groups in the target population who were previously less likely to come forward for testing.
However, our study indicated that there may have been a disparity in the impact of the campaign on different
population groups. The content and delivery of ongoing and future information campaigns aimed at increasing
chlamydia screening should be carefully developed so that they are relevant to all sections of the target
population.
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Genital Chlamydia trachomatis is the most commonly
diagnosed bacterial sexually transmitted infection (STI)
in the UK. The prevalence is highest in sexually active
adults aged under 25 years [1,2]. Infections are primarily
asymptomatic but if left untreated can result in serious
long term complications [3].
In 2003, the National Chlamydia Screening Programme
(NCSP) was established in England to increase the early
detection and treatment of asymptomatic infection in
sexually active people aged under 25 years, in a range of
settings [4]. Since its inception, there has been an increase
in the proportion of young people being screened for
chlamydia, and in 2010 it was estimated that 25% of all
15–24 year olds were tested for chlamydia [5]. However,
the proportion of people screened has remained below the
estimated 35% coverage which, at the time of the study,
was deemed necessary to significantly reduce the preva-
lence of chlamydia [6,7].
Mass media campaigns have been used for a range of
health-related areas and have successfully achieved desir-
able changes in behaviour and the use of healthcare
services amongst young people [8-11]. In January 2010, the
mass media campaign, “Chlamydia. Worth talking about”,
was launched nationally with the aim of increasing the pro-
portion of people aged 15–24 years having a chlamydia test
in NCSP. The campaign sought to normalise conversations
about the transmission of chlamydia, raise awareness of the
risk of untreated infection and explain the process of diag-
nosis and treatment. The mass-media campaign with na-
tional TV, radio, on-line and poster advertising ran for a
total of four weeks and resources (leaflets, posters and ac-
cess to logos) were made available for local campaigns
which continued throughout February and March [12]. The
campaign material consisted of short faceless dialogues
about chlamydia infection, diagnosis and treatment set in
everyday situations and voiced by young people from a
range of socio-demographic groups. The uptake of screen-
ing amongst 15–24 year olds was identified by the cam-
paign developers as an indicator to evaluate the campaign.
To date, a qualitative evaluation of the campaign, based
on pre and post campaign interviews with 1400 children
and young people found an increase in the awareness of
and testing for chlamydia, however, it did not assess ac-
tual changes in chlamydia screening uptake [13]. The aim
of this study was to evaluate quantitatively, using an
interrupted time series analysis, the immediate impact of
the campaign on the coverage and test positivity within
the NSCP by socio-demographic characteristics and self-
reported sexual behaviour.
Methods
We undertook retrospective analysis using anonymised
data routinely collected from the NCSP over a 27 monthperiod (1st April 2008 to 30th June 2010). Each test rec-
ord included information on the clinical source of the
sample, test result, patient’s clinical history, area of resi-
dence, socio-demographic information (ethnicity, age
and sex) and self-reported sexual behaviour.
A unique patient identifier based on post code of resi-
dence, date of birth and sex was created to de-duplicate
the dataset. Socio-economic status for each patient was
based on the overall indices of multiple deprivation
(IMD) 2007 rank of their postcode of residence [14].
Patients were assigned to one of 10 Strategic Health Au-
thority (SHA) areas according to the Primary Care Trust
(PCT) code. Within the NCSP dataset, patients are
assigned to one of 22 ethnic groups, which we redefined
into four groups: “White”, “Black”, “Asian” and “Other”.
Patient age was categorised as 15–19 and 20–24 years.
Patients in the NCSP data were assigned to one of three
sexual behaviour risk groups according to their response
to two questions on sexual behaviour associated with
higher risks of chlamydia infection; new sexual partner
in last three months and two or more sexual partners in
last 12 months. Patients were defined as “High risk” if at
least one question was yes, “Low risk” if both questions
were no and “Unknown risk” if both questions were un-
answered or if either question is unanswered when the
other was recorded as no [15].
The patients were assigned to a pre-campaign phase
(1st April 2008 to 31st December 2009), campaign phase
(1st January to 31st March 2010) and post campaign
phase (1st April to 30th June 2010) according to the date
of their tests. Patients were excluded from all analyses if
tests were for clinical reasons, contacts of known cases,
and from prisons or military services.
The NCSP is hosted by the Public Health England and
permission for the use of the NSCP data was sought
through the NCSP Programme. Ethical approval was not
needed.Coverage
Coverage was calculated as the number of tests performed
in each month using as the denominators mid 2007 popu-
lation estimates of ethnicity by sex and age-group for each
SHA publically available from the Office for National
Statistics (ONS) [16]. The population estimate of ethnicity
by socio-economic class was not available and we assumed
that the distribution of socio-economic class by sex and for
each age-group for the whole SHA population was the
same for each ethnic group. Records with missing sex,
ethnic group, socio-economic class, SHA or age group were
excluded from the analysis because of the unavailability of a
comparable population denominator. The SHA denomin-









Military: n = 33,771
Prisons: n = 32,014
Clinical: n = 9,369
Contact: n = 18,804
Unknown/equivocal result: n = 0 
Excluded
Sex unknown: n = 6491 
Ethnicity unknown: n = 560,134
SHA unknown: n = 48,147 
Figure 1 Flowchart of records included in the final coverage
and positivity analysis.
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Positivity was defined as the proportion of positive tests
in each month. Patients with missing, unknown or
equivocal test results were excluded from the analysis.
Statistical analysis
An interrupted time series analysis was performed in three
stages. Stage I: crude estimates were obtained by ignoring
all other possible sources of variation in the data. Stage II:
secular and cyclical (seasonal) trends were then incorpo-
rated to estimate the effect of the campaign after allowing
for time trends and seasonality. Stage III analysis extended
this to a multivariable mixed effects model by adding SHA
as a random effect to allow for the possibility of significant
variation between SHAs and the SHA differences were
not of interest. The remaining variables as fixed effects
and interaction of the socio-demographic fixed effects
with phase.
In both stage II and III analyses, month (each taking one
of twenty-seven different values) and quarter (each taking
one of four different values) were taken as continuous and
categorical variables, respectively. The appropriate form of
the secular trend was ascertained by assuming a cubic trend
and reducing complexity in a stepwise manner when sim-
pler trends did not fit significantly worse (p ≥ 0.05). This
was followed, in stage III, by removing non-significant in-
teractions one at a time. The final model was reached when
all main effects and interactions were significant.
Coverage, analysis involved negative binomial regression
with number of tests as the outcome and the population as
the offset (denominator). For positivity, logistic regression
was used with number of positive tests as outcome and
total number of unequivocal tests as the denominator. Like-
lihood ratio testing was used to obtain p-values, except
where indicated when Wald testing was employed. Stage III
estimates and their 95% confidence intervals for variables
not involved in interactions were obtained from the final
model. The remainder were obtained from single inter-
action models. Estimates were risk ratios (RR) for coverage
and odds ratios (OR) for positivity.
A sensitivity stage I and II analysis of including into the
coverage and excluding from the positivity those individuals
with unknown socio-demographics was performed as a
check on robustness of results.
Given that people could have re-attended for screening
during the 27 months under investigation, lag analyses
using one and two month time lags were undertaken to
assess the impact of non-independence in our data. The
analysis was undertaken in Stata 10.
Results
Data
Following de-duplication, data on 2,263,869 tests were
reported for the 27 months under investigation. Afterexcluding 4% of the records for people tested in military
clinics (33,771), prisons (32,014), tests undertaken for
clinical reasons (9,369) and contacts of cases (18,804),
2,169,911 records were available for analysis. None of
the remaining records had an unknown or equivocal test
result and so 2,169,911 records were included in the
positivity analysis. A final total of 1,555,139 records were
included in the coverage analysis following the exclusion
of 28% of the records where the sex, ethnicity or SHA
was unknown or missing (Figure 1).
Coverage
There were secular and cyclical trends in the chlamydia
testing observed in the 27 months data collected by the
NCSP (Figure 2). The number of people tested for chla-
mydia increased every month from April 2008 through
to July 2010 and there was a considerable increase in
quarter 4 (01st January to 31st March) compared to
quarter 3 (01st October to 31st December) for both
2008/09 and 2009/10.
The majority of people tested before, during and
after the campaign period were female, aged between
15–19 years, of White ethnicity and were from the most
deprived social group (Table 1). However, the proportion
of males increased during the campaign (from 30.6%
pre-campaign to 39.3% during the campaign), while the
proportion of people of Black ethnicity fell from 6.2% in
the pre-campaign phase to 5.0% during the campaign
phase.
During the campaign there was a crude increase in
chlamydia testing compared with the pre-campaign
Figure 2 Number of Chlamydia tests and proportion positive from 1st April 2008 to 30th June 2010.
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the post campaign phase, although it remained higher than
the pre-campaign period (RR: 1.38; 95% CI: 1.37-1.38)
(Table 2). When cyclical and secular trends were adjusted
for, there was no change in the overall coverage in both the
campaign phase (RR: 0.91; 95% CI: 0.72-1.14) and post
campaign phase (RR: 0.88; 95% CI: 0.69-1.11) compared to
the pre campaign phase (Table 2).
Coverage for males and females and for the four ethnic
groups varied between the three phases, but did not vary
across the phases by age group or socio-economic status.
Compared to the pre-campaign phase, males were more
likely to be screened during the campaign (RR: 1.09; 95%
CI: 1.02-1.19) but less likely in the post campaign phase
(RR: 0.91; 95% CI: 0.83-0.99).
The coverage by ethnicity also varied during and after
the campaign compared to the pre-campaign phase. Indi-
viduals of Black (RR: 0.78; 95% CI: 0.71-0.86) and Other
(RR: 0.81; 95% CI: 0.74-0.90) ethnic groups were less likely
to be tested during the campaign, and did not differ in the
post campaign phase. People of Asian origin were more
likely to be tested during the campaign (RR: 1.116; 95%
CI: 1.008-1.235) but less likely, although not significantly,
in the post campaign period (RR 0.98; 95% CI: 0.88-1.09).
Those of White ethnicity were less likely to be
screened in the post campaign phase as compared to
the pre-campaign phase (RR: 0.79; 95% CI: 0.72-0.88).
Positivity
Positivity also demonstrated secular and cyclical
trends; there was an overall decline in the positivityduring the 27 months with a greater drop in quarter
4 as compared with quarter 3 for both 2008/09 and
2009/10 (figure 2). A higher percentage of females,
people aged 20–24 years, of Black ethnicity, from the
most deprived social group and high risk sexual be-
haviour group tested positive for chlamydia before,
during and after the campaign. The percentage of
people testing positive for all sub groups decreased
during the campaign phase and remained lower in
the post campaign phase as compared with the pre-
campaign phase (Table 3).
The crude overall positivity rate was lower in the
campaign phase as compared with the pre-campaign
phase (OR: 0.70; 95%CI: 0.69-0.71) (Table 4). The
positivity rate increased in the post campaign phase
but remained lower than the pre-campaign period (OR:
0.77; 95% CI: 0.76-0.79). Adjusting for secular and
cyclical trends, the positivity rate during the campaign
was higher than the pre-campaign phase (OR: 1.18;
95% CI 1.13-1.23) and further increased in the post-
campaign phase (OR: 1.40; 95% CI 1.30-1.51) (Table 4).
The positivity rate increased in the campaign and
post campaign phase for all sub groups analysed. The
following sub-groups had a greater increase in propor-
tion testing positive during the campaign as compared
with the pre-campaign phase: women (OR: 1.19; 95%
CI 1.14 – 1.25), people aged 20–24 years old (OR: 1.20;
95% CI 1.15 – 1.26), in the least deprived social groups
(OR: 1.17; 95% CI 1.10 – 1.25), from non-White ethnic
groups and people with high risk sexual behaviour
(OR: 1.21; 95% CI 1.17-1.27).
Table 1 Demographic characteristics of individuals included in each phase for the coverage analyses
Characteristic Pre – no. tested During – no. tested Post – no. tested
(% of total tested) (% of total tested) (% of total tested)
Total Tested 1025863 327675 201601
(100) (100) (100)
Sex Male 313692 128818 70278
(30.58) (39.31) (34.86)
Female 712171 198857 131323
(69.42) (60.69) (65.14)
Age-group 15-19 years 573332 185464 110161
(55.89) (56.60) (54.64)
20-24 years 452531 142211 91440
(44.11) (43.40) (45.36)
Socio-economic class 1 (most deprived) 298433 93523 62265
(29.09) (28.54) (30.89)
2 236452 76224 46812
(23.05) (23.26) (23.22)
3 186571 61181 36530
(18.19) (18.67) (18.12)
4 161345 51181 30145
(15.73) (15.62) (14.95)
5 (least deprived) 143062 45566 25849
(13.95) (13.91) (12.82)
Ethnicity White 876975 283011 172849
(85.49) (86.37) (85.74)
Black 63885 16247 11519
(6.23) (4.96) (5.71)
Asian 36938 14453 8522
(3.60) (4.41) (4.23)
Other 48065 13964 8711
(4.69) (4.26) (4.32)
*614,772 (28%) Observations excluded because of missing/unknown sex, deprivation, age and ethnicity.
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Our study found that the overall uptake of testing
(coverage) did not appear to be affected by the national
campaign, as the apparent increase in testing was not
maintained after the secular and cyclical trends in
testing were taken into account. However, we found a
differential change in the coverage in the various socio-
demographic groups both during and after the cam-
paign. Testing in women and people of Black and Other
ethnic origins fell during the campaign, while testing of
men and people of Asian ethnicity increased. However,
the increases in testing in these groups were not
sustained after the campaign.
The overall proportion of people testing positive in-
creased during the campaign, an observation that
persisted in the immediate post campaign phase afteradjusting for secular and cyclical trends in positivity.
The campaign was associated with an increase in the
positivity of chlamydia infections detected for all socio-
demographic and risk groups, including people defined
as having high risk sexual behaviour.
Since 2008, there has been a steady increase in the num-
ber of people tested for chlamydia through the NCSP asso-
ciated with previous and ongoing national and local
initiatives such as national targets, use of financial incen-
tives and professional education programmes to promote
screening [17-20]. In addition, in the last quarter of each fi-
nancial year (January to March), there have been marked
increases in testing observed which have coincided with the
requirement for local services to meet national coverage
targets set by the Department of Health [20]. However,
these initiatives and annual targets have had an equal and
Table 2 Relative change in testing during and after the campaign and by socio-demographic characteristics
Campaign Phase RR (95% CI) P value
STAGE I
Crude RR Pre 1 <0.001~
During 2.23 (2.22 to 2.41)
Post 1.38 (1.37 to 1.38)
STAGE II
Adjusted RRx Pre 1 0.50~
During 0.91 (0.72 to 1.14)
Post 0.88 (0.69 to 1.11)
STAGE III
Sexx Male Pre 1 <0.001~
During 1.10 (1.02 to 1.19)
Post 0.91 (0.84 to 0.99)
Female Pre 1
During 0.71 (0.66 to 0.77)
Post 0.72 (0.66 to 0.79)
Age-groupx 15-19 years 1 <0.001*
20-24 years 0.67 (0.65 to 0.69)
Socio-economic classx 1 (most deprived) 1 <0.001*
2 0.59 (0.57 to 0.62)
3 0.38 (0.36 to 0.39)
4 0.27 (0.26 to 0.28)
5 (least deprived) 0.23 (0.22 to 0.24)
Ethnicityx White Pre 1 <0.001~
During 0.91 (0.83 to 1.00)
Post 0.79 (0.72 to 0.88)
Black Pre 1
During 0.78 (0.71 to 0.86)
Post 0.74 (0.67 to 0.82)
Asian Pre 1
During 1.12 (1.01 to 1.24)
Post 0.98 (0.88 to 1.09)
Other Pre 1
During 0.81 (0.74 to 0.90)
Post 0.75 (0.67 to 0.83)
Legend: RR, Risk ratio; CI, Confidence interval x adjusted for cyclical and secular trends, *Wald test for socio-demographic variable, ~ likelihood ratio test for
interaction in stage III, phase in stages I and II.
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were recruited to the NCSP for testing [21]. Our study
demonstrates that the increase in the number of people
tested during the campaign phase was not greater than
what would be expected for that time of year. However, the
proportion of people testing positive during the campaign
phase was more than expected and resulted in a smaller
than anticipated reduction in positivity for January to
March 2010.A review of the positivity within the NCSP during
2007/08 found that women and people of black and
mixed ethnicity were more likely to be tested by the
programme and attributed this discrepancy in recruit-
ment to the design and delivery of local services and ini-
tiatives [20]. In contrast, our results indicate that, unlike
previous initiatives, this campaign was associated with
an overall higher positivity and may have had some suc-
cess in targeting groups such as men, people of Asian
Table 3 Demographic characteristics of individuals included in each phase for the positivity analyses
Characteristic Pre – no. tested During – no. tested Post – no. tested
(% positive) (% positive) (% positive)
Total tested 1417873 468009 284029
(6.65) (4.72) (5.22)
Sex Male 458812 193775 104740
(5.60) (3.68) (4.32)
Female 954824 272873 178396
(7.16) (5.47) (5.75)
Sex unknown 4237 1361 893
(6.09) (4.63) (3.70)
Age-group 15-19 year 808334 272737 158652
(6.56) (4.43) (5.00)
20-24 years 609539 195272 125377
(6.78) (5.14) (5.49)
Socio-economic class 1 (most deprived) 403063 129909 87207
(7.89) (5.59) (5.90)
2 325252 108604 64290
(6.82) (4.82) (5.36)
3 253380 87668 50397
(6.09) (4.42) (4.92)
4 212359 71750 41427
(5.85) (4.21) (4.94)
5 (least deprived) 186474 63326 36255
(5.16) (3.79) (4.20)
unknown 37345 6752 4453
(7.56) (4.80) (4.11)
Ethnicity White 905090 287450 175135
(6.94) (5.06) (5.58)
Black 66128 16785 12042
(8.25) (6.61) (7.51)
Asian 37882 14763 8778
(2.28) (1.66) (1.88)
Other 49532 14260 8934
(7.64) (6.00) (6.63)
unknown 359241 134751 79140
(5.95) (3.98) (4.29)
Sexual behaviour High risk 552570 152441 93649
(8.81) (6.87) (7.16)
Low risk 330365 89744 50719
(4.66) (3.28) (4.00)
unknown 534938 225824 139661
(5.65) (3.85) (4.36)
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Table 4 Relative change in positivity of Chlamydia testing during and after the campaign and by socio-demographic
characteristics
Campaign Phase OR (95% CI) P value*
STAGE I
Crude OR Pre 1 <0.001
During 0.70 (0.67 to 0.71)
Post 0.77 (0.76 to 0.79)
STAGE II
Adjusted ORx Pre 1 <0.001
During 1.18 (1.13 to 1.23)
Post 1.40 (1.30 to 1.51)
STAGE III
Sexx Male Pre 1 <0.001
During 1.04 (0.99 to 1.10)
Post 1.30 (1.20 to 1.41)
Female Pre 1
During 1.19 (1.14 to 1.25)
Post 1.35 (1.25 to 1.46)
unknown Pre 1
During 1.26 (0.88 to 1.81)
Post 0.85 (0.50 to 1.43)
Age-groupx 15-19 years Pre 1 <0.001
During 1.10 (1.05 to 1.15)
Post 1.31 (1.21 to 1.42)
20-24 years Pre 1
During 1.20 (1.15 to 1.26)
Post 1.37 (1.27 to 1.48)
Socio-economic classx 1 (most deprived) Pre 1 0.005
During 1.13 (1.08 to 1.19)
Post 1.30 (1.20 to 1.41)
2 Pre 1
During 1.13 (1.07 to 1.19)
Post 1.34 (1.24 to 1.46)
3 Pre 1
During 1.16 (1.10 to 1.22)
Post 1.36 (1.25 to 1.48)
4 Pre 1
During 1.16 (1.09 to 1.23)
Post 1.44 (1.32 to 1.57)
5 (least deprived) Pre 1
During 1.17 (1.10 to 1.25)
Post 1.36 (1.24 to 1.49)
unknown Pre 1
During 1.06 (0.93 to 1.20)
Post 0.98 (0.81 to 1.17)
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Table 4 Relative change in positivity of Chlamydia testing during and after the campaign and by socio-demographic
characteristics (Continued)
Ethnicityx White Pre 1 <0.001
During 1.15 (1.10 to 1.20)
Post 1.35 (1.25 to 1.46)
Black Pre 1
During 1.25 (1.15 to 1.35)
Post 1.57 (1.41 to 1.75)
Asian Pre 1
During 1.25 (1.05 to 1.49)
Post 1.40 (1.13 to 1.74)
Other Pre 1
During 1.25 (1.14 to 1.37)
Post 1.46 (1.29 to 1.65)
unknown Pre 1
During 1.08 (1.03 to 1.14)
Post 1.23 (1.13 to 1.33)
Sexual behaviourx High risk Pre 1 <0.001
During 1.21 (1.16 to 1.27)
Post 1.36 (1.25 to 1.46)
Low risk Pre 1
During 1.10 (1.04 to 1.17)
Post 1.42 (1.30 to 1.55)
unknown Pre 1
During 1.08 (1.03 to 1.13)
Post 1.28 (1.18 to 1.39)
Legend OR, Odds ratio; CI, Confidence interval x adjusted for cyclical and secular trends *likelihood ratio test for interaction in stage III, phase in stages I and II.
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that were previously not typically recruited to the NCSP.
Our study contributes to the limited and inconsistent
evidence base of evaluations of mass media campaigns
aimed at promoting chlamydia testing. Two studies
measuring the impact of multi-media campaigns for
chlamydia screening found that both the awareness of
and information seeking behaviours of the target popula-
tions increased and in one study persisted for weeks
after the campaign finished [22,23]. However, neither of
the studies ascertained the impact on subsequent testing
behaviour. A further three studies have measured the
effect of multi-media campaigns on chlamydia testing
uptake. Evaluations of campaigns in Denmark and
Australia concluded that their campaigns did not in-
crease chlamydia testing [24,25]. While an evaluation of
another campaign in Australia found that chlamydia
testing increased significantly for both men and women
during the media campaign and was closely paralleled by
an increase in chlamydia notifications. However, in that
study the investigators did not control for cyclical or
secular longer-term trends [26].The timing and type of broadcast, the overall duration
of campaigns as well as the integration with other cam-
paigns have been identified as key to the success of pub-
lic information campaigns and are likely to account for
the discrepancy in the impact of the campaigns run to
date [27]. The English campaign aimed to promote com-
munication between individuals to encourage safer sex-
ual behaviours and attitudes. Thus, a range of voices
were used instead of casting people to deliver the key
messages in order to appeal to a wider audience. The
qualitative evaluation of the campaign demonstrated an
increase in the number of young people aware of
chlamydia and who claimed to have had a test as a result
of the campaign. However, over two fifths of those
interviewed felt that the campaign was not relevant to
them, which may explain why we observed differential
effects of the campaign on coverage and positivity in the
various socio-demographic groups [13].
We have identified a number of limitations with this
study. The NCSP dataset analysed includes data from
services that are part of the NCSP programme. An esti-
mated two thirds of chlamydia tests are conducted at
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analysis may have underestimated the effect of the
campaign [28].
Our analysis assumed that the changes in testing and
positivity that occurred during and after the campaign
phase were as a result of campaign only. The use of the
already available NSCP dataset meant that we were un-
able to collect any additional data, such as the motiv-
ation for testing from those who were tested. We did
not take into account any concurrent local campaigns or
incentive schemes aimed at health professionals and/or
young people which have previously been used to in-
crease chlamydia screening and which may have been
used during the campaign phase to target high risk indi-
viduals [29,30].
It is likely that people would have attended for chla-
mydia testing on more than one occasion in the
27 months from April 2008 to July 2010 and so in
addition to de-duplicating our dataset our analysis in-
cluded an assessment for correlation. This lag analysis
produced very similar results to those presented. How-
ever, the choice of lag period was limited by the number
of months of data available for analysis and it is possible
that results could have materially changed if there was
correlation for time periods of more than two months
and would have been missed by our assessment.
The exclusion of just under 30% of all records from
the coverage analysis could potentially bias our results.
We believe that this is unlikely as the results from the
sensitivity analysis were not substantively different to
those presented. A similar conclusion was reached with
the sensitivity analysis of the positivity data (Additional
file 1). Finally, we also assumed that the distribution of
people by socioeconomic group was the same for all
ethnic groups. This decision was taken on pragmatic
grounds, although there is evidence that some ethnic
groups are more likely to live in areas of greater
deprivation [31].
Conclusion
This study adds to the limited evidence base of the ef-
fectiveness of media campaigns on chlamydia testing
uptake and to date is the only study to assess the effect
of the campaign by socio-demographic characteristics
and self-reported sexual behaviour. The media cam-
paign, once secular and cyclical trends were controlled
for, was associated with an increased testing of high
risk individuals and groups in the target population
who were previously less likely to come forward for
testing.
Our findings corroborate the claims of positive behav-
iour changes reported in the qualitative evaluation and
together indicate that there may have been a disparity in
the impact on different population groups. The contentand delivery of information campaigns aimed at increas-
ing chlamydia screening therefore need to be carefully
developed to ensure that they are relevant to all sections
of the target population.
This study also demonstrates the potential value of
using routine national surveillance data to determine the
effectiveness of population wide initiatives.
Additional file
Additional file 1: Coverage and Positivity of chlamydia testing
before during and after the “Chlamydia, Worth Talking About”
campaign.
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